FOLH1 and neoplasm: In this setting, a potential application of whole-body dynamic PET could be the stratification of patient candidates for RLT based on the dynamic uptake pattern and the degree of binding and internalization of PSMA radiopharmaceuticals in both tumor lesions and the parotid gland.